Skip to main content

Ashion Analytics Genomic Enabled Medicine Cancer Panel

Ashion Analytics has launched the Genomic Enabled Medicine (GEM) cancer panel designed to improve cancer care. This cancer panel covers the coding regions of 562 cancer-related genes, and also captures copy number events and structural variations. The panel also produces detailed genomic analysis of a patient's cancer. Employing state-of-the-art tumor (somatic)-germline subtraction technology, the GEM cancer panel approach uncovers true tumor events, said Ashion Analytics in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.